Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Iris Neidt"'
Autor:
Reinhard Büttner, Eva Wardelmann, Volkmar H. J. Hans, Nicola Speidel, Iris Neidt, Sabine Merkelbach-Bruse, Torsten Pietsch, Thomas Heinicke, Inge Losen, Erhard Bierhoff
Publikováno v:
International Journal of Cancer. 106:887-895
Gastrointestinal stromal tumors (GISTs) typically express high levels of the Kit-receptor. The majority of GISTs carry mutations in the c-kit protooncogene clustering in exon 11. The significance of c-kit mutations for the biological behavior of GIST
Autor:
Eva, Wardelmann, Inge, Losen, Volkmar, Hans, Iris, Neidt, Nicola, Speidel, Erhard, Bierhoff, Thomas, Heinicke, Torsten, Pietsch, Reinhard, Büttner, Sabine, Merkelbach-Bruse
Publikováno v:
International journal of cancer. 106(6)
Gastrointestinal stromal tumors (GISTs) typically express high levels of the Kit-receptor. The majority of GISTs carry mutations in the c-kit protooncogene clustering in exon 11. The significance of c-kit mutations for the biological behavior of GIST
Autor:
Christoph Manegold, Eva Wardelmann, Hans-Peter Fischer, Ulrich Pfeifer, Iris Neidt, Erhard Bierhoff, Torsten Pietsch, Nicola Speidel
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 15(2)
Gastrointestinal stromal tumors (GISTs) coexpress CD34 and the Kit tyrosine-kinase receptor (CD117). A subset of GISTs carry gain-of-function mutations of the c-kit proto-oncogene in its juxtamembrane domain. The relationship between the mutational s
Autor:
Pablo Hernáiz-Driever, Bernd Wilken, Iris Neidt, Thomas Schröder, Stephan Probst-Cousin, Bernhard Lüscher, Markus Bergmann, Torsten Pietsch, Folker Hanefeld, Jochen Herms, Peter Schürmann, Hans A. Kretzschmar, Annete Sommer, Julianne Behnke
Publikováno v:
International journal of cancer. 89(5)
To identify prognostic factors in medulloblastoma, a common malignant brain tumor of childhood, expression of the oncogene c-myc was examined at the mRNA level by in situ hybridization. c-myc mRNA expression was observed in 30 of 72 tumors (42%). The
Autor:
Eva Wardelmann, Inge Losen, Volkmar Hans, Iris Neidt, Nicola Speidel, Erhard Bierhoff, Thomas Heinicke, Torsten Pietsch, Reinhard Büttner, Sabine Merkelbach-Bruse
Publikováno v:
International Journal of Cancer; 10/10/2003, Vol. 106 Issue 6, p887-895, 9p